Cite

HARVARD Citation

    Ritchie, E. et al. (2022). Patient-reported outcomes of patients with myelofibrosis or essential thrombocythemia enrolled in the MOST study. Leukemia & lymphoma. 63 (13), pp. 3138-3153. [Online]. 
  
Back to record